Together, these findings suggest that tau accumulation localized to subregions of the entorhinal cortex provides additional specificity compared to accumulation quantified in larger segmentations, therefore highlighting the importance of examining associations between localized tau burden and cognitive variability for improving the characterization of individual disease trajectories and identifying those individuals who are on a trajectory of decline due to AD. This evidence concerns the gene MAPT and Alzheimer disease.